Secondary hyperparathyroidism persists after renal transplantation in a substantial number of patients. Primary hyperparathyroidism and secondary hyperparathyroidism are both associated with abnormalities in glucose metabolism, such as insufficient insulin release and glucose intolerance. The association of hyperparathyroidism and diabetes after renal transplantation has, as far as we know, not been studied. Our aim was to investigate whether hyperparathyroidism is associated with new-onset diabetes mellitus after transplantation (NODAT) during the first year posttransplantation
Background : Our study was undertaken to investigate the pathogenesis and possible risk factors for ...
Our study was focused on identification and correction of early hyperglycaemia, with the aim to redu...
New-onset diabetes after transplantation (NODAT) is nowadays a prominent long-term problem in renal ...
New onset diabetes after transplant (NODAT/PTDM), also known as post-transplant diabetes mellitus (P...
The pathophysiology underlying new-onset diabetes after transplantation (NODAT) is unresolved. We ob...
The pathophysiology underlying new-onset diabetes after transplantation (NODAT) is unresolved. We ob...
The development of new onset diabetes after transplantation (NODAT) is associated with increased car...
WOS: 000400322000009PubMed ID: 28262264Aim: New-onset diabetes after transplantation (NODAT) is a fr...
Background and objectives: New-onset diabetes after transplantation (NODAT) represents a primary cau...
Abstract Disorders in mineral metabolism and secondary hyperparathyroidism (sHPT) are well known com...
New-onset diabetes after transplantation (NODAT) is a frequent and severe complication after renal ...
Background New Onset Diabetes After Transplantation (NODAT) is an important complication of renal tr...
New-onset diabetes after transplantation (NODAT) is an important metabolic complication of transplan...
New-onset diabetes after transplant (NODAT) has been reported to occur in 4%-25% of renal transplant...
OBJECTIVEdWe determined prevalence, risk factors, phenotype, and pathophysiological mechanism of new...
Background : Our study was undertaken to investigate the pathogenesis and possible risk factors for ...
Our study was focused on identification and correction of early hyperglycaemia, with the aim to redu...
New-onset diabetes after transplantation (NODAT) is nowadays a prominent long-term problem in renal ...
New onset diabetes after transplant (NODAT/PTDM), also known as post-transplant diabetes mellitus (P...
The pathophysiology underlying new-onset diabetes after transplantation (NODAT) is unresolved. We ob...
The pathophysiology underlying new-onset diabetes after transplantation (NODAT) is unresolved. We ob...
The development of new onset diabetes after transplantation (NODAT) is associated with increased car...
WOS: 000400322000009PubMed ID: 28262264Aim: New-onset diabetes after transplantation (NODAT) is a fr...
Background and objectives: New-onset diabetes after transplantation (NODAT) represents a primary cau...
Abstract Disorders in mineral metabolism and secondary hyperparathyroidism (sHPT) are well known com...
New-onset diabetes after transplantation (NODAT) is a frequent and severe complication after renal ...
Background New Onset Diabetes After Transplantation (NODAT) is an important complication of renal tr...
New-onset diabetes after transplantation (NODAT) is an important metabolic complication of transplan...
New-onset diabetes after transplant (NODAT) has been reported to occur in 4%-25% of renal transplant...
OBJECTIVEdWe determined prevalence, risk factors, phenotype, and pathophysiological mechanism of new...
Background : Our study was undertaken to investigate the pathogenesis and possible risk factors for ...
Our study was focused on identification and correction of early hyperglycaemia, with the aim to redu...
New-onset diabetes after transplantation (NODAT) is nowadays a prominent long-term problem in renal ...